Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 97
Filter
1.
BMC Infect Dis ; 23(1): 827, 2023 Nov 24.
Article in English | MEDLINE | ID: mdl-38001444

ABSTRACT

BACKGROUND: Sepsis in low-birth-weight neonates remains one of the most significant causes of neonatal morbidity and mortality. Approximately 3 million newborns suffer from sepsis globally every year. The aim of this study was to compare demographic and clinical features, as well as etiology and antibiotic susceptibility, of the main pathogens related to neonatal sepsis in two neonatal intensive units during a two-year period. METHODS: We observed early-onset (EO-BSI) and late-onset bloodstream infections (LO-BSI) cases in two high-reference neonatal intensive care units (NICU) over a 24-month period (2016-2017). Samples of patients' blood were tested for the presence of the microorganisms. All bacterial isolates were tested for susceptibility to antibiotics. RESULTS: The majority of sepsis cases weighed above 1000 g and were born by cesarean section. About 10% of the EO-BSI group died. There were differences in the EO-BSI /LO-BSI ratio in the compared wards due to differences among the admitted children. The most common pathogens isolated from blood were coagulase-negative staphylococci (CoNS) were represented by two dominating species: S. epidermidis and S. haemolyticus, followed by Klebsiella spp. strains and E.coli, which were mostly found in EO-BSI cases. No single S. agalactiae (GBS) strain was isolated. The majority of CoNS strains were resistant to methicillin, half were resistant to aminoglycosides, and one-third were resistant to macrolides and lincosamides. Half of the Gram-negative rods were resistant to beta-lactams. CONCLUSIONS: The epidemiology of sepsis in two observed NICUs is comparable to data obtained from other studies with a predominance of methicillin-resistant CoNS in LO-BSI and beta-lactam resistant E. coli in EO-BSI. It is of importance that the campaign for controlling GBS carriage in pregnant women in Poland resulted in the disappearance of GBS as a cause of sepsis. Unfortunately, there are no such measures to control E.coli related sepsis.


Subject(s)
Neonatal Sepsis , Sepsis , Child , Humans , Infant, Newborn , Female , Pregnancy , Neonatal Sepsis/epidemiology , Neonatal Sepsis/drug therapy , Intensive Care Units, Neonatal , Cesarean Section , Poland/epidemiology , Escherichia coli , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Sepsis/microbiology , Staphylococcus , Retrospective Studies
2.
Eur J Clin Microbiol Infect Dis ; 36(9): 1643-1649, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28401320

ABSTRACT

Streptococcus pyogenes (GAS) is one of the major human pathogenic bacteria that cause a wide range of diseases. Currently, increased incidence of streptococcal invasive infections is observed worldwide. In this study, we focused on the prevalence of genes encoding superantigens and type M proteins in the population of GAS strains from invasive versus non-invasive infections. We tested 253 GAS strains: 48 strains from patients with invasive infections (18 from wound/deep skin localization, 30 from women in labour) and 205 strains from non-invasive forms (147 from common infections of the upper respiratory, 49 from the vagina of females with genital tract infections and 9 from non-invasive wound and superficial skin infections). Significant differences were found in the occurrence of genes: speG, speI, speJ and smeZ, which were more common in GAS isolated from invasive than from non-invasive strains; speJ and smeZ occurred more frequently in strains from invasive perinatal infections versus strains from women without symptoms of invasive infection; speH and speI in strains from invasive skin/wound infection versus strains isolated from non-invasive wound and superficial skin infections. Emm types 1 and 12 predominated in the group of strains isolated from superficial infections and type 28 in those from puerperal fever. Occurrence of genes encoding virulence factors is common in genomic DNA of most of S. pyogenes, regardless whether these streptococcal infections are invasive or non-invasive. On the other hand, it appears that strains with speG, speI, speJ and smeZ genes may have a particular potential for virulence.


Subject(s)
Streptococcal Infections/epidemiology , Streptococcal Infections/microbiology , Streptococcus pyogenes/genetics , Streptococcus pyogenes/pathogenicity , Virulence Factors/genetics , Antigens, Bacterial/genetics , Bacterial Outer Membrane Proteins/genetics , Carrier Proteins/genetics , Female , Genotype , History, 21st Century , Humans , Male , Serogroup , Streptococcal Infections/diagnosis , Streptococcal Infections/history , Streptococcus pyogenes/classification , Virulence/genetics
3.
Eur J Clin Microbiol Infect Dis ; 35(5): 747-54, 2016 May.
Article in English | MEDLINE | ID: mdl-26873375

ABSTRACT

Invasive group A streptococcal (GAS) infections constitute an important epidemiological problem. Many cases occur in women during the postnatal period. The objective of this study was to evaluate the presence of the genes responsible for production of iron-chelating protein (perR) and superantigens (speA, speB, speC, speF, speG, speH, speI, speJ, speK, speL, speM, smeZ, and ssa) in S. pyogenes strains isolated from invasive infections in women after delivery. Furthermore, this study sought to verify whether S. pyogenes strains show special phenotypic and genotypic (sla, spy1325) characteristics that may play a decisive role in adherence to the genital tract epithelium. Moreover, the emm-types and antibiotic susceptibility were determined. We tested 30 invasive S. pyogenes strains isolated from postpartum invasive infection and 37 GAS control strains isolated from the genital tracts of asymptomatic multiparous women. The majority of the tested strains were shown to express two types of emm genes (1 and 28), though emm -12, -28, -75 and -89 were uniquely expressed in the group of strains isolated from invasive infections. A significantly higher prevalence of perR in the strains from puerperal fever was shown. Significant differences were also found between the two groups with respect to the incidence of the genes related to adherence; GAS strains originating from women with sepsis/puerperal fever showed presence of these genes less frequently than those of the control group. Although differences in frequencies of the gene coding for various superantigens were noted between the compared groups of GAS strains, they were not significant.


Subject(s)
Pregnancy Complications, Infectious/microbiology , Streptococcal Infections/microbiology , Streptococcus pyogenes/pathogenicity , Bacterial Adhesion/genetics , Drug Resistance, Bacterial , Female , Genes, Bacterial , Genotype , Humans , Microbial Sensitivity Tests , Pregnancy , Serogroup , Streptococcus pyogenes/classification , Streptococcus pyogenes/drug effects , Streptococcus pyogenes/genetics , Virulence Factors/genetics
4.
J Pediatr Urol ; 12(1): 36.e1-6, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26320394

ABSTRACT

OBJECTIVE: The aim of this study was to analyze antibiotic resistance and virulence patterns in Pseudomonas aeruginosa (PAR) isolates from urinary tract infections among children in Southern Poland. MATERIALS AND METHODS: This study comprised consecutive, non-repetitive PAR isolates sent from two collaborative laboratories. The study group consisted of children aged up to 17 years from Southern Poland with culture-proven PAR UTIs. Relevant information about patients with UTIs, such as age, sex, and type of infection (polymicrobial or monomicrobial), was collected. Isolates were screened for major virulence factors found in uropathogenic PAR strains. Multidrug-resistant (MDR) strains were defined as strains not susceptible to one antimicrobial in at least three different antimicrobial classes. Extensively drug resistant (XDR) strains were defined as strains susceptible to no more than two antimicrobial classes. RESULTS: The total prevalence of PAR UTIs was 2.1%, and in children <5 years of age it was 3.0%. A total of 26 isolates was tested: 21 from outpatients and five from inpatients. Most infections (80.8%) occurred in children ≤ 4 years of age. The most prevalent virulence gene was exoY (96.2%). The prevalence of other effector proteins was 88.5% for exoT, 92.3% for exoS, and 19.2% for exoU. The gene for LasB was present in 80.8% of isolates; the gene for AprA in 61.5%; the gene for PilA in 19.2%; and the gene for PilB was not detected. The PAR isolates were generally susceptible to beta-lactam and aminoglycoside antimicrobials. All isolates were also susceptible to colistin. A large proportion of isolates were resistant to carbapenems and fluoroquinolones (Fig. 1). No significant differences were found in antimicrobial resistance between males and females or inpatients and outpatients (p > 0.05 for all tested antimicrobials), or in antimicrobial resistance between younger (≤ 5 years old, n = 21) and older (> 5 years old, n = 5) children (p > 0.05 for all tested antimicrobials). Two isolates were classified as XDR and none as MDR. The EDTA test yielded one MBL-positive isolate (3.8%), from a 17-year-old patient in home care. No isolates with genes for the KPC, IMP, or VIM were identified. CONCLUSION: As data on UTIs in children with Pseudomonas etiology are scarce, this paper provides useful information for clinicians and allows for comparison between Poland and other countries. Our findings have important implications for clinicians treating UTIs empirically, because the success of empiric treatment is based on knowledge of pathogen antimicrobial susceptibility patterns.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Drug Resistance, Bacterial , Pseudomonas aeruginosa/pathogenicity , Urinary Tract Infections/microbiology , Urinary Tract/microbiology , Adolescent , Child , Child, Preschool , Female , Follow-Up Studies , Humans , Incidence , Infant , Male , Poland/epidemiology , Retrospective Studies , Urinary Tract Infections/drug therapy , Urinary Tract Infections/epidemiology , Virulence
5.
Clin Microbiol Infect ; 21(12): 1047-51, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26417851

ABSTRACT

Hand hygiene is considered to be the most effective way of preventing microbial transmission and healthcare-associated infections. The use of alcohol-based hand rubs (AHRs) is the reference standard for effective hand hygiene. AHR consumption is a valuable surrogate parameter for hand hygiene performance, and it can be easily tracked in the healthcare setting. AHR availability at the point of care ensures access to optimal agents, and makes hand hygiene easier by overcoming barriers such as lack of AHRs or inconvenient dispenser locations. Data on AHR consumption and availability at the point of care in European hospitals were obtained as part of the Prevention of Hospital Infections by Intervention and Training (PROHIBIT) study, a framework 7 project funded by the European Commission. Data on AHR consumption were provided by 232 hospitals, and showed median usage of 21 mL (interquartile range (IQR) 9-37 mL) per patient-day (PD) at the hospital level, 66 mL/PD (IQR 33-103 mL/PD) at the intensive-care unit (ICU) level, and 13 mL/PD (IQR 6-25 mL/PD) at the non-ICU level. Consumption varied by country and hospital type. Most ICUs (86%) had AHRs available at 76-100% of points of care, but only approximately two-thirds (65%) of non-ICUs did. The availability of wall-mounted and bed-mounted AHR dispensers was significantly associated with AHR consumption in both ICUs and non-ICUs. The data show that further improvement in hand hygiene behaviour is needed in Europe. To what extent factors at the national, hospital and ward levels influence AHR consumption must be explored further.


Subject(s)
Anti-Infective Agents, Local/administration & dosage , Hand Disinfection/methods , Hand Sanitizers/administration & dosage , Cross Infection/prevention & control , Europe , Health Surveys , Hospitals/statistics & numerical data , Humans , Point-of-Care Systems/statistics & numerical data
6.
Infection ; 41(1): 1-8, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23086684

ABSTRACT

OBJECTIVE: The objective of this study was to evaluate the epidemiology of infection in Polish long-term care facilities (LTCFs) and to analyse the capabilities and legitimacy of implementing continuous targeted surveillance. METHODS: The study investigated the relationship between the presence of infection and health status, tested using a point prevalence study (PPS) and incidence study. A 1-day PPS was carried out in October 2009, with prospective continuous surveillance between December 2009 and November 2010. Infections were defined according to McGeer's criteria. RESULTS: The surveillance encompassed 193 people. The prevalence was 14.0 % in residential homes (RHs) and 18.7 % in the nursing home (NH). Various types of infections (in the PPS) were observed significantly more frequently in patients with asthma, wounds, atherosclerosis of lower extremities, tracheotomy tubes and conditions in patients hospitalised in intensive care units (ICUs) up to 1 year before the PPS day. The incidence rate was 2.7/1,000 patient days (pds). CONCLUSIONS: The factors determined to be important for the risk of infection (in the continuous study) include the general status of patients, expressed using Barthel, abbreviated mental and Katz scales, as well as limited physical activity, stool incontinence and urinary catheterisation. In the PPS study, only a slight relationship was shown between the general status of residents and the risk of infection. None of the general status scales used clinically were shown to be helpful in estimating that risk, similarly to the five-point physical activity scale. Prospective continuous surveillance shows a possibility of limiting the range of infection control in the LTCFs within targeted surveillance in a population of patients that requires intensive nursing procedures. As a marker, one could point to the low score in the Barthel or Katz scales or low physical activity/bedridden persons.


Subject(s)
Communicable Disease Control , Infections/epidemiology , Residential Facilities , Female , History, 21st Century , Humans , Incidence , Infections/etiology , Infections/history , Male , Poland/epidemiology , Population Surveillance , Prevalence
7.
Przegl Epidemiol ; 66(3): 513-9, 2012.
Article in Polish | MEDLINE | ID: mdl-23230725

ABSTRACT

AIM: The study presents the results of the analysis of antibiotic consumption and its direct costs in selected neonatal units. MATERIAL AND METHODS: Data were collected retrospectively (the year 2007) in five hospitals, during the pilot phase of the Polish Neonatal Network . Antibiotic consumption was assessed using the Defined Daily Dose (DDD). The costs were assessed as the costs of purchase of one DDD. RESULTS: The study included 11 922 children hospitalized in the period from 1.01 to 31.12.2007. In this group, 731 infants have birth weight < 1500 grams (from 2.2% to 64.2% in individual units, median--7.3%). The mean consumption of antibacterial drugs was 48.52 DDD/1 000 person-days (P-D) of stay among the entire study population (median--42,52), and varied from 23.13 to 85.82 DDD/1,000 P-D. However, this difference has not been statistically significant. The most commonly used group of antibiotics were beta-lactams--in four out of five units the percentage of its usage ranged from 48.71% to 74.67%. Next group were aminoglicosides--in one unit its usage reached 56.97% and in other ranged from 5.01% to 22.53%. Glycopeptides and macrolides were also used in every unit of the studied group. The usage of glycopeptides ranged from 1.7% to 10.81% and of macrolides from 1.32% to 15.71%. Different kinds of antibiotics were used occasionally. The differences of costs of purchase of one DDD between hospitals were greater and varied from 17,64 PLN/ DDD to 84,58 PLN/ DDD (average costs). A considerable range of costs index values was also noted for different groups of antibiotics. The costs of purchase of one DDD of beta-lactams varied from 19.54 PLN/ DDD to 68.35 PLN/ DDD; for aminoglicosides the cost varied from 4.61 PLN/ DDD to 122.9 PLN/ DDD, for glycopeptides--from 31.40 PLN/ DDD to 283.13 PLN/ DDD and in case of macrolides: from 12.05 PLN/ DDD to 90.77 PLN/ DDD. This differentiation of the cost of purchasing a single defined daily dose, taking into account the specific groups of antibiotics, did not have the characteristics of statistical significance. CONCLUSIONS: As expected, the antibiotic regimens in the studied wards were similar. This is due to a homogeneous population of hospitalized patients. However, the differences of costs of purchase of antibiotics observed in the study, indicate the considerable variety of the treatment patterns in Polish neonatology units and the need to develop and implement recommendations of effective pharmacotherapy for patients in intensive neonatal care units and the implementation of a unified model of infections surveillance.


Subject(s)
Anti-Bacterial Agents/economics , Anti-Bacterial Agents/therapeutic use , Drug Utilization/statistics & numerical data , Intensive Care Units, Neonatal/economics , Drug Utilization Review , Glycopeptides/economics , Glycopeptides/therapeutic use , Humans , Infant, Newborn , Length of Stay/economics , Macrolides/economics , Macrolides/therapeutic use , Poland , Retrospective Studies , beta-Lactams/economics , beta-Lactams/therapeutic use
8.
Epidemiol Infect ; 140(2): 329-36, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21489340

ABSTRACT

Serotyping, subtyping and genotyping are important tools for epidemiological studies of group B streptococci (GBS). We investigated the genotype distribution of 353 GBS isolates originating from vaginal or rectal carriage to identify capsular serotypes and subtypes based on the surface protein genes of the alpha-like protein (Alp) family. GBS were recovered from 30% of 1176 pregnant women during the period 2007-2009, with a predominance of capsular genotypes III (35%), Ia (20%), V (17%), II (15%), Ib (8%) and IV (5%). The most common Alp gene was epsilon (26%), followed by rib (22%), alp2 (21%), bca (17%) and alp3 (14%). Several protein genes were significantly associated (G(2)=249·635, P<0·0001) with particular serotypes: epsilon with Ia, Ib, IV; bca with Ib, II; rib with II, III; alp3 with V; alp2 with III. High genetic diversity within GBS strains was observed using DNA macrorestriction. Serotypes Ib, II and III demonstrated the greatest genetic heterogeneity and serotype V the lowest heterogeneity (relative frequency coefficient ≥0·03 vs. -0·46, respectively). Macrolide-resistant strains with serotype V and alp3 gene, showed higher uniformity in genetic profile. The distribution of serotypes and surface proteins of GBS strains are necessary data to inform the design and formulation of new GBS vaccines for use in Poland and other countries.


Subject(s)
Bacterial Capsules/genetics , Bacterial Proteins/genetics , Electrophoresis, Gel, Pulsed-Field/methods , Membrane Proteins/genetics , Streptococcus agalactiae/classification , Streptococcus agalactiae/genetics , Adult , Carrier State/microbiology , DNA, Bacterial/genetics , Female , Genetic Variation , Genotype , Humans , Phylogeny , Poland , Polymerase Chain Reaction , Pregnancy , Rectum/microbiology , Serotyping , Streptococcus agalactiae/isolation & purification , Vagina/microbiology
9.
Clin Microbiol Infect ; 17(10): 1589-92, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21848974

ABSTRACT

A 24-year-old female patient developed sepsis resulting from preoperative administration of probiotics following an aortic valve replacement. Blood cultures revealed the causative agent to be the probiotic Lactobacillus rhamnosus, which has recently been implicated as an emerging aetiology of infection in those taking probiotics. In the past few years, probiotic use in hospitals has increased greatly. However, there is growing global evidence that the use of probiotics in patients with organ failure, immunocompromised status and dysfunctional gut barrier mechanisms can cause infections. This and other reports show the importance of establishing generally recognized safety guidelines.


Subject(s)
Aortic Valve/surgery , Lacticaseibacillus rhamnosus/pathogenicity , Probiotics/adverse effects , Sepsis/etiology , Adult , Electrophoresis, Gel, Pulsed-Field , Female , Genotype , Hospitals , Humans , Probiotics/administration & dosage , Probiotics/standards , Sepsis/microbiology
10.
Clin Microbiol Infect ; 16(9): 1442-7, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20041902

ABSTRACT

The present study reports the epidemiological investigations undertaken in one of Krakow's city hospitals regarding the source of infection and the routes of transmission of a group A streptococcus (Streptococcus pyogenes), using fluorescent in situ hybridization as a rapid method for detecting S. pyogenes carriage in the medical personnel involved. Four patients from the gynaecology department and two patients from the surgery department presented with clinical signs of infection. Characteristics of the S. pyogenes strains isolated from patients and from one medical staff member, including the emm gene and superantigens encoding genes, are described. All patients (four confirmed and two probable cases) survived; the operating theatre aid was identified as an S. pyogenes carrier and the source of the infections.


Subject(s)
Cross Infection/epidemiology , Cross Infection/microbiology , Disease Outbreaks , Streptococcal Infections/epidemiology , Streptococcal Infections/microbiology , Streptococcus pyogenes/classification , Streptococcus pyogenes/genetics , Antigens, Bacterial/genetics , Bacterial Outer Membrane Proteins/genetics , Bacterial Typing Techniques , Carrier Proteins/genetics , Carrier State/epidemiology , Carrier State/microbiology , Cluster Analysis , Female , Genotype , Hospitals , Humans , In Situ Hybridization, Fluorescence , Molecular Typing , Poland/epidemiology , Streptococcus pyogenes/isolation & purification
11.
J Physiol Pharmacol ; 60 Suppl 6: 49-54, 2009 Dec.
Article in English | MEDLINE | ID: mdl-20224151

ABSTRACT

Bacteria in the gut play a central role in the initiation and progress of inflammatory bowel disease (IBD). This study was prepared to elucidate the role in the inflammatory process of the bacterial species which are able to produce hydrogen peroxide, present in samples taken from colon lesions in adolescents with inflammatory bowel disease. Fifty eight adolescents were enrolled into the study from January 2004 to October 2006 in Cracow, Poland. Biopsies and stool samples were collected. Bacteriological examinations and measurements of hydrogen peroxide production by enterococci, streptococci and lactobacilli were performed. For the first time it has been shown here that HP producing bacteria may contribute to increased amounts of hydrogen peroxide in the inflamed mucosa of Crohn's disease and ulcerative colitis patients. Moreover, we have been able to demonstrate an increase of total populations of aerobic bacteria but not anaerobes in the studied samples of mucosa of adolescents with inflammatory bowel disease which is an indirect evidence of higher oxygen tension present in inflamed tissues in IBD. We have also been able to demonstrate the direct relationship between presence of blood in stools of IBD adolescents and increased populations of Enterobacteriaceae but not streptococci in samples of colon mucosa. It is, therefore, possible that different products of Enterobacteriaceae and especially their lipopolysaccharides may also contribute to perpetuation of the chronic colon inflammation.


Subject(s)
Bacteria, Aerobic/metabolism , Colon/microbiology , Enterobacteriaceae/metabolism , Hydrogen Peroxide/metabolism , Inflammatory Bowel Diseases/microbiology , Adolescent , Bacteria, Aerobic/isolation & purification , Enterobacteriaceae/isolation & purification , Feces/microbiology , Humans , Inflammatory Bowel Diseases/metabolism , Inflammatory Bowel Diseases/pathology , Lipopolysaccharides/metabolism , Occult Blood , Poland
12.
J Physiol Pharmacol ; 60 Suppl 6: 55-60, 2009 Dec.
Article in English | MEDLINE | ID: mdl-20224152

ABSTRACT

A series of in vitro experiments was arranged to assess effects of different concentrations of H(2)O(2) contained in bacterial cultures on apoptosis and necrosis of HT-29 line cells representing human gut epithelium. On the basis of cytofluorimetric assays it was possible to demonstrate that supernatant of the Lactobacillus strain producing hydrogen peroxide (L. delbrueckii CU/22) was able to induce both apoptosis and necrosis in human epithelial culture cells HT-29. Both effects were more prominent than those visible under influence of supernatant of the non-H(2)O(2)-producing Lactobacillus strain or chemically pure H(2)O(2) at the same concentration used as a control. In the light of this study and also other reports on damaging effects of hydrogen peroxide and superoxide radicals of bacterial origin on colonic cells, commensal bacteria of the human gut producing H(2)O(2) may be involved in pathomechanisms of IBD by perpetuating the inflammatory reaction and increasing apoptosis and necrosis. There is a promise that probiotic preparations containing Lactobacillus bacteria will be successful as adjunct therapy of IBD and it is, therefore, postulated to make a very careful selection of the Lactobacillus strains as candidates for probiotics indicated to ameliorate the course of IBD, before starting clinical trials.


Subject(s)
Apoptosis , Colonic Neoplasms/microbiology , Gastric Mucosa/pathology , Hydrogen Peroxide/metabolism , Inflammatory Bowel Diseases/microbiology , Lactobacillus delbrueckii/metabolism , Probiotics/adverse effects , Gastric Mucosa/drug effects , HT29 Cells , Humans , Hydrogen Peroxide/pharmacology , Necrosis , Probiotics/metabolism
13.
Infection ; 36(1): 36-40, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18193388

ABSTRACT

BACKGROUND: The aim of the study was to analyse the epidemiological and microbiological analysis of surgical site infections in patients that underwent knee or hip endoarthroplasty procedures. MATERIALS AND METHODS: The epidemiological and microbiological surveillance was carried out by the local infection control team in cooperation with the Department of Bacteriology, at the Chair of Microbiology, Jagiellonian University Medical College in Cracow. RESULTS: A total of 651 patients operated in the Department of Orthopedics, Trauma Surgery and Rehabilitation of Cracow Rehabilitation Center in Poland were analyzed. Twenty-three cases of SSI were detected. The cumulative incidence after hip prosthesis (HPRO) procedures was 2.3%, while for knee prosthesis (KPRO) it was 7.0. Standardized risk index, comparing the incidence in our study to German hospitals, shows a statistically significant, higher incidence in patients with knee replacement procedures in our study (p=0.004). Among etiological agents of SSIs, we demonstrated the dominating role of Gram-positive cocci to be 75% (30% methicillin resistant). This resistance was confirmed only in case of coagulasenegative staphylococci (no MRSA were cultured). Gramnegative rods were isolated with a frequency of 25%: 41.6% in SSI after hip endoarthroplasty and 15% after knee endoarthroplasty. Postdischarge surveillance encompassed 59% of operated patients. CONCLUSION: The incidence of SSIs of hip prosthesis in our study was comparable to the incidence in the German KISS program, where surveillance is integrating a highly sensitive postdischarge detection. On the other hand, we observed a higher, statistically significant cumulative incidence in case of knee endoarthroplasty. Our microbiological data show effective control of methicillin-resistant Staphylococcus aureus and are also in agreement with the data found in literature referring to coagulasenegative multi-resistant staphylococci as an important problem in the orthopaedic surgery of the knee joint.


Subject(s)
Arthroplasty, Replacement, Hip , Arthroplasty, Replacement, Knee , Surgical Wound Infection/epidemiology , Adult , Aged , Cross Infection/epidemiology , Cross Infection/microbiology , Female , Follow-Up Studies , Humans , Incidence , Male , Middle Aged , Patient Discharge , Poland/epidemiology , Risk Factors , Staphylococcal Infections/epidemiology , Staphylococcal Infections/microbiology , Surgical Wound Infection/etiology , Surgical Wound Infection/microbiology
14.
Int J Exp Pathol ; 88(3): 155-64, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17504445

ABSTRACT

Chronic active colitis (including inflammatory bowel disease - IBD) is maintained by a variety of pro-inflammatory mediators. Certain intestinal bacterial strains may induce colitis, whereas some strains (e.g. Lactobacillus spp.) show a protective effect in colitis owing to their anti-inflammatory activity. In this study, we have examined the production of selected inflammatory cytokines, reactive oxygen species (ROS), nitric oxide (NO) and the expression of haeme oxygenase-1 (HO-1) by murine peritoneal macrophages stimulated in vitro by the intestinal bacterial strains, isolated from mice with colitis. Lactobacillus strains (Lactobacillus reuteri, L. johnsonii, L. animalis/murinus) and two potentially pathogenic bacteria (Escherichia coli and Enterococcus faecalis) induced the production of substantial amounts of cytokines with a strain specific profile. Despite some interstrain differences, all lactobacilli induced production of anti-inflammatory cytokines (IL-10(high), IL-6(low), IL-12p70(low)). Conversely, E. faecalis and E. coli induced the production of proinflammatory cytokines (TNF-alpha, IL-12p70), the cytokines essential for chronic IBD. Macrophages released comparably substantial amounts of ROS in response to all Lactobacillus strains tested, while E. coli and E. faecalis ability to induce generation of ROS was negligible. In contrast to ROS, the production of NO/NO(2) (-) by macrophages activated with all bacterial strains tested was similar. Moreover, for the first time, it has been shown that intestinal bacteria differed in their ability to induce expression of HO-1, a stress-inducible enzyme with antioxidant and anti-inflammatory properties. The beneficial immunoregulatory properties of candidate probiotic bacteria for the treatment of IBD are discussed.


Subject(s)
Colitis/immunology , Colitis/microbiology , Enterococcus faecalis/physiology , Escherichia coli/physiology , Lactobacillus/physiology , Macrophages/immunology , Animals , Cells, Cultured , Cytokines/immunology , Female , Heme Oxygenase-1/metabolism , Luminescence , Mice , Mice, Inbred CBA , Nitric Oxide/metabolism , Phagocytosis , Probiotics , Reactive Oxygen Species/metabolism , Species Specificity
15.
Aliment Pharmacol Ther ; 23(2): 247-53, 2006 Jan 15.
Article in English | MEDLINE | ID: mdl-16393304

ABSTRACT

BACKGROUND: Multiple studies document that probiotics are effective in treating infectious diarrhoea in children. Lactobacillus rhamnosus GG is the most extensively studied but effectiveness of other strains has been poorly examined. AIM: To determine whether L. rhamnosus strains (573L/1; 573L/2; 573L/3) (Lakcid L, Biomed, Lublin, Poland) would be effective in shortening infectious diarrhoea. METHODS: In a randomized, double-blind, placebo-controlled trial, 87 children (age range: 2 months to 6 years) with infectious diarrhoea were administered Lakcid L at a dose 1.2 x 10(10) CFU or placebo, twice daily, for 5 days. Primary outcome measure was the duration of diarrhoea. Secondary measures were duration of parenteral rehydration, adverse events, and gastrointestinal tract colonization by administered strains. RESULTS: In an intention to treat analysis of 87 children, the mean duration of diarrhoea in the treated group: 84 +/- 56 h; placebo: 96 +/- 72 h (P = 0.36). In rotavirus infection: 76 +/- 35 h vs. 115 +/- 67 h (P = 0.03), respectively. Duration of parenteral rehydration: 15 +/- 14 h vs. 38 +/- 33 h (P = 0.006). Gut colonization by administered strains was 80% and 41% at five and 14 days, respectively. No adverse events were noted. CONCLUSIONS: Administration of L. rhamnosus strains shortens the duration of rotaviral diarrhoea in children but not of diarrhoea of any aetiology. Intervention shortens the time of intravenous rehydration.


Subject(s)
Diarrhea/therapy , Lacticaseibacillus rhamnosus , Probiotics/therapeutic use , Acute Disease , Child , Child, Preschool , Diarrhea/diet therapy , Diarrhea/microbiology , Double-Blind Method , Female , Fluid Therapy/methods , Humans , Infant , Intestines/microbiology , Male , Rotavirus Infections/therapy , Time Factors , Treatment Outcome
16.
J Physiol Pharmacol ; 57 Suppl 9: 5-12, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17242483

ABSTRACT

Probiotics discussed in this paper are evaluated using the WHO/FAO definition from 2001. The authors present a brief description of the normal microbiota of the gastrointestinal tract, discuss probiotics in the aspects of gut immunity and then move to selection of bacterial strains as probiotics. The main issue raised is the critical evaluation of probiotics in randomized clinical trials for conditions such as: infectious diarrhoea; antibiotic associated diarrhoea; inflammatory bowel disease; pouchitis and diverticulitis; H. pylori infection; irritable bowel syndrome. Safety of probiotics is mentioned with respect to susceptible individuals and bacterial translocation. As a conclusion the authors again recall the strain specific actions of probiotics in different clinical situations and that so far probiotics play a role in rotaviral and post antibiotic diarrhoea and pouchitis. An important issue still to be solved in order to confidently recommend probiotics as efficacious therapy is the regulatory aspect of probiotics.


Subject(s)
Gastrointestinal Diseases/therapy , Gastrointestinal Tract/microbiology , Lactobacillus , Probiotics/therapeutic use , Gastrointestinal Diseases/immunology , Gastrointestinal Diseases/microbiology , Gastrointestinal Tract/immunology , Humans , Immunity, Mucosal , Lactobacillus/immunology , Probiotics/adverse effects , Treatment Outcome
17.
J Hosp Infect ; 48 Suppl A: S47-9, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11759026

ABSTRACT

Handwashing is the most important and least expensive measure for preventing transmission of hospital-acquired infections. Nevertheless, healthcare workers do not seem to understand the risks associated with non-compliance. Thus, compliance is usually poor and rarely exceeds 40%. The Polish Society of Hospital Infection has made a short study of handwashing practices in Polish hospitals as observed by members of infection control teams. The study was based on questionnaires given to infection control workers attending the annual congress of the society. The workers were asked to complete the forms during the congress according to their perceived estimations. Altogether 78 complete questionnaires were analysed. The responding staff members were from hospitals of all sizes, reference levels and regions. Nearly all (95.6%) hospitals had a written protocol for handwashing procedures but according to the estimates of their infection control teams, the compliance rates varied from 20 to 80% although in most institutions was between 40% and 60%. In the vast majority of the hospitals, alcoholic rub preparations were used (70.3%), but in some both handwashing with chlorhexidine in detergents and alcohol-based antiseptics were used in different situations. According to the respondents, the mean time of hand disinfection varied from 1 to 3 min. The handwashing procedures were mostly performed in examination, operating and patients' rooms. Thus, it seems that as in other countries, Polish healthcare workers fail to understand the importance of handwashing.


Subject(s)
Guideline Adherence/statistics & numerical data , Hand Disinfection/methods , Infection Control Practitioners , Personnel, Hospital , Anti-Infective Agents, Local/pharmacology , Attitude of Health Personnel , Chlorhexidine/pharmacology , Detergents/pharmacology , Ethanol/pharmacology , Hand Disinfection/standards , Health Knowledge, Attitudes, Practice , Hospital Bed Capacity/statistics & numerical data , Humans , Infection Control Practitioners/education , Infection Control Practitioners/psychology , Inservice Training , Needs Assessment , Personnel, Hospital/education , Personnel, Hospital/psychology , Poland , Societies, Hospital , Surveys and Questionnaires
18.
Med Dosw Mikrobiol ; 53(2): 133-42, 2001.
Article in Polish | MEDLINE | ID: mdl-11757422

ABSTRACT

Antagonistic activity of Lactobacillus strains has been known for some time. This property is connected with production of many active substances by lactobacilli e.g., organic acids and bacteriocin-like substances which interfere with other indigenous microorganisms inhabiting the same ecological niche, including also anaerobic gastrointestinal tract pathogens. Growing interest of clinical medicine in finding new approaches to treatment and prevention of common inflammatory infections of the digestive tract resulted in studies on a possible usage of lactic acid bacteria. Last years, several in vitro and in vivo experiments on antagonism of different Lactobacillus strains against Helicobacter pylori and Clostridium difficile were performed. These observations had been done on already established, well known probiotic Lactobacillus strains. We tested antibacterial activities of Lactobacillus strains isolated from human digestive tract. As indicator bacteria, four species known as anaerobic bacterial etiologic agents of gastroenteric infections: Helicobacter pylori, Campylobacter jejuni, C. coli and Clostridium difficile were used. Some of them were obtained from international collections, others were clinical isolates from specimens taken from patients with different defined gastrointestinal infections. We used a slab method of testing inhibitory activity described in details previously. Following conclusions were drawn from our study: All tested human Lactobacillus strains were able to inhibit the growth of all strains of anaerobic human gastrointestinal pathogens used in this study. Inhibitory activities of tested Lactobacillus strains against Helicobacter pylori, Campylobacter spp., and Clostridium difficile as measured by comparing mean diameters of the inhibition zones were similar. Differences in susceptibility of individual indicator strains of Campylobacter spp. and Clostridium difficile to inhibitory activity of Lactobacillus strains were small. A similar mechanism of inhibition of anaerobic bacteria by lactobacilli is postulated.


Subject(s)
Campylobacter coli/growth & development , Campylobacter jejuni/growth & development , Clostridioides difficile/growth & development , Digestive System/microbiology , Helicobacter pylori/growth & development , Lactobacillus/physiology , Gastroenteritis/microbiology , Humans
19.
Med Sci Monit ; 6(2): 291-9, 2000.
Article in English | MEDLINE | ID: mdl-11208325

ABSTRACT

Bacterial infection of the bile system appears to be an important factor in the formation of stones. In view of the hypothesis that strains of E. c. form an essential factor in infections of the bile ducts, an attempt has been made to determine the connection between infections of the bile ducts and the adherence of E. c. to the epithelium of the gallbladder. The research covered 148 patients operated electively for cholecystolithiasis (121), cholecystocholedocholithiasis (26) and recurrent lithiasis (1). In bile collected from the gallbladder in the course of the operation, E. coli strains were isolated. Cholangioscopy performed in 26 patients enabled the macroscopic evaluation and grading of inflammatory lesions of bile duct mucosa. The mucosa of the gallbladder was evaluated histologically. The adherence test was performed using homologous and heterologous strains of E. c. isolated from the bile of gallstone patients. The adherence occurred most frequently in the neck of the gallbladder (71-100%) in those patients in whom an infectious process of the bile ducts mucosa was endoscopically diagnosed. The adherence of bacteria to the epithelium of the gallbladder did not depend on the type of inflammation (acute, chronic).


Subject(s)
Bacterial Adhesion , Bile Ducts/microbiology , Bile/microbiology , Cholelithiasis/etiology , Bile Ducts/pathology , Cholelithiasis/microbiology , Cholelithiasis/pathology , Escherichia coli/isolation & purification , Escherichia coli/pathogenicity , Escherichia coli Infections/etiology , Escherichia coli Infections/microbiology , Escherichia coli Infections/pathology , Female , Humans , Inflammation/diagnosis , Inflammation/etiology , Inflammation/microbiology , Male
20.
Przegl Epidemiol ; 54(3-4): 259-69, 2000.
Article in Polish | MEDLINE | ID: mdl-11349588

ABSTRACT

Hospital-acquired pneumonia (HAP) is one of the most frequently occurring hospital infections in the world. This study describes the incidence of HAP in Poland, as well as the specific risk factors leading to this type of infection in Polish hospitals; including those of patient age, length of hospitalization, and use of mechanical ventilation. The epidemiology of HAP as well as treatment resistance of various causal organisms was studied. Data for this study was acquired from the Registry of Hospital-acquired Infectious Diseases for the year 1998. Out of 329,608 hospital-acquired infections in all patients except newborns, 920 were found to be HAP. This study showed that of every 1000 hospital admissions three patients developed HAP (0.3%). Death occurred in 260 of 920 HAP cases or 30%; and HAP found to be the direct cause of death in 66 of the 260 cases (25%). The greatest incidence of HAP was found to occur in patients older than 75 years, was directly related to the length of hospital stay, and was higher in patients on mechanical ventilation longer than 10 days. The most frequently isolated causal agents were the Gram-negative rods (Pseudomonas aeruginosa, Acinetobacter sp., Klebsiella sp., Enterobacter sp.), and Staphylococcus aureus. Streptococcus pneumoniae and Haemophilus influenzae were found in only 2% and 4% of cases, respectively, and thus were the least likely causes of HAP in this population. It was found that the percentage of methicillin-resistant strains of Staphylococcus aureus was very high (55% to 60%); vancomycin-resistant enterococci were only found in patients who did not undergo surgery. The isolated strains of Pseudomonas aeruginosa showed marked resistance to chinolones (58-76%) and to imipen (approximately 20%). In the Enterobacteriaceae family, Klebsiella sp. was found to be resistant to third-generation cephalosporins (56-73%) and Enterobacter sp. resistant in 55% to 81% of the isolates.


Subject(s)
Cross Infection/epidemiology , Cross Infection/microbiology , Pneumonia/epidemiology , Pneumonia/microbiology , Adolescent , Adult , Age Distribution , Aged , Child , Child, Preschool , Drug Resistance, Microbial , Humans , Incidence , Infant , Intensive Care Units/statistics & numerical data , Length of Stay/statistics & numerical data , Middle Aged , Poland/epidemiology , Respiration, Artificial/statistics & numerical data , Risk Factors , Survival Rate
SELECTION OF CITATIONS
SEARCH DETAIL
...